World’s First Next-Generation Protein Sequencing Device to Accelerate the Study of Diseases and Pandemics
The Quantum-Si ecosystem encompasses everything required to decode the molecules of life, including sample preparation, sequencing, and data analysis. The transition from analog to digital proteomics enables a new generation of more sensitive and accurate research tools and diagnostics.
FDA Designation of Basal-IQ Technology as an Interoperable Automated Glycemic Controller Announced by Tandem Diabetes Care
The company reports this is the second system to receive iAGC designation by the FDA, following the Company’s clearance of the t:slim X2™ insulin pump with Control-IQ™ technology in December 2019.
FX Solutions Receives FDA 510k Clearances for Glenoid Baseplate With a Central Screw and 32mm Glenosphere and Humeral Cups
FX Solutions notes the addition of the glenoid baseplate with a central screw allows surgeons perioperative options to address a variety of deficiencies and can now accommodate an even larger patient population and surgeon's needs.
Interim Efficacy Data from eCoin Pivotal Trial Reported
Valencia Technologies announced 6-month interim efficacy data from its eCoin Pivotal Clinical Trial. The announcement follows the podium presentation of the interim data at the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) 2020 Annual Meeting on February 28th, 2020.
Acquisition of Vigilenz Completed Reports Bactiguard
All conditions precedent have been fulfilled and the first part of the total consideration, consisting of a cash payment of USD 4.5 million, has been paid. The remaining part of the consideration, 241 512 new class B-shares in Bactiguard, is subject to approval by the annual general meeting of shareholders in Bactiguard on 28 April 2020.